You are viewing a free preview of this lesson.
Subscribe to unlock all 8 lessons in this course and every other course on LearningBro.
This lesson is mapped to AQA 7402 Section 3.6.2 — synaptic transmission (refer to the official AQA specification document for exact wording). Synapses are the chemical junctions between neurones, or between neurones and effectors. They are the points at which the nervous system performs the computational work that distinguishes it from a passive wire: every decision, every act of selective attention, every memory, every reflex modulation occurs by integration of excitatory and inhibitory signals at synapses. Charles Sherrington's framework of the nervous system as a network of competing excitations and inhibitions remains the conceptual basis of contemporary neuroscience — at A* level you are expected to deploy this framing rather than describe the synapse as a one-step relay.
The discovery that synaptic transmission is chemical rather than electrical is associated with Otto Loewi, whose night-time dream experiment (paraphrased here as his vagus-stimulation perfusion demonstration of an inhibitory chemical messenger released from one frog heart that slowed a second isolated heart) supplied the foundational evidence that what crosses the synapse is a soluble molecule, not a current. Loewi's "Vagusstoff" was later identified as acetylcholine, the prototype neurotransmitter and the focus of A-Level treatment.
Key Definition: A synapse is the junction between two neurones, consisting of the presynaptic membrane, the synaptic cleft (approximately 20 nm wide), and the postsynaptic membrane. Communication across the synapse is usually chemical, involving the release of a neurotransmitter from synaptic vesicles by Ca²⁺-dependent exocytosis.
The most commonly studied synapse at A-Level is the cholinergic synapse, which uses acetylcholine (ACh) as its neurotransmitter. The neuromuscular junction is a specialised cholinergic synapse; cholinergic synapses are also found in the brain (basal forebrain), autonomic ganglia, and in parasympathetic effector targets. The key structural components are:
graph TD
A["Action potential<br/>arrives at presynaptic knob"] --> B["Voltage-gated Ca²⁺ channels open"]
B --> C["Ca²⁺ enters down gradient"]
C --> D["Vesicles fuse with presynaptic membrane"]
D --> E["ACh released by exocytosis<br/>into 20 nm cleft"]
E --> F["ACh diffuses across cleft<br/>less than 0.5 ms"]
F --> G["ACh binds to nicotinic receptor"]
G --> H["Na⁺ channel opens<br/>EPSP generated"]
H --> I["Threshold reached?"]
I -->|yes| J["AP fires in postsynaptic neurone"]
I -->|no| K["Decays / waits for more input"]
H --> L["AChE hydrolyses ACh"]
L --> M["Choline reabsorbed via active transport"]
M --> N["ACh re-synthesised from choline + acetyl CoA"]
style D fill:#27ae60,color:#fff
style G fill:#3498db,color:#fff
style L fill:#e74c3c,color:#fff
The following steps describe transmission at a cholinergic synapse and form the backbone of any extended exam response:
An action potential arrives at the presynaptic knob, depolarising the presynaptic membrane.
Voltage-gated Ca²⁺ channels open in the presynaptic membrane, and Ca²⁺ ions diffuse into the presynaptic knob down their steep electrochemical gradient (Ca²⁺ outside ~2 mM; Ca²⁺ inside ~100 nM at rest, a 20,000-fold gradient).
Ca²⁺ causes synaptic vesicles to move to and fuse with the presynaptic membrane. The calcium ions bind to vesicle-associated proteins (the SNARE complex), triggering exocytosis.
ACh is released into the synaptic cleft by exocytosis. Approximately 300 vesicles release their contents per action potential at a typical CNS bouton.
ACh diffuses across the synaptic cleft (this takes less than 0.5 ms due to the narrow width of the cleft and the small size of the ACh molecule).
ACh binds to specific receptors on the postsynaptic membrane. The receptors are nicotinic cholinergic receptors at the neuromuscular junction.
The receptor changes shape, opening the associated ligand-gated Na⁺ channel. Na⁺ ions flow into the postsynaptic cell down their electrochemical gradient.
The postsynaptic membrane is depolarised, producing a local potential called an excitatory postsynaptic potential (EPSP) of typically 0.5–1 mV per quantum of ACh release.
If sufficient EPSPs summate (spatially or temporally) to reach the threshold (~−55 mV) at the axon hillock, an action potential is generated in the postsynaptic neurone.
ACh is hydrolysed by the enzyme acetylcholinesterase (AChE) in the synaptic cleft, producing choline and ethanoic acid (acetic acid). AChE is one of the fastest enzymes known — it can hydrolyse approximately 25,000 ACh molecules per second.
Choline is reabsorbed into the presynaptic knob by an Na⁺-coupled active transport system and recycled to synthesise more ACh using acetyl CoA from mitochondria, catalysed by ChAT.
Ca²⁺ is actively pumped out of the presynaptic knob (or back into intracellular stores), resetting the bouton for the next action potential.
Exam Tip: Learn this sequence thoroughly — exam questions frequently ask you to describe the events at a synapse in order. Always mention Ca²⁺ ions causing vesicle fusion, the role of acetylcholinesterase in removing ACh, and the recycling of choline. An A* discriminator is naming the quantal nature of ACh release (one vesicle = one quantum) and the role of Ca²⁺ as the trigger, not as a structural component of the vesicle.
The simultaneous presence of EPSPs and IPSPs at a single postsynaptic neurone is the computational substrate of the entire nervous system — Sherrington's "common path" of converging excitatory and inhibitory influences.
Because a single EPSP is usually too small to reach threshold, the nervous system uses summation to determine whether an action potential is generated:
Synapses are essential for nervous system function for several reasons:
Unidirectional transmission: Neurotransmitter is only released from the presynaptic side and receptors are only on the postsynaptic side, ensuring impulses travel in one direction only across the synapse (even if the axon itself can in principle conduct in either direction).
Amplification (divergence): One presynaptic neurone can stimulate many postsynaptic neurones, amplifying the signal — a single motor neurone may innervate hundreds of muscle fibres.
Integration (convergence): Many presynaptic neurones can converge on one postsynaptic neurone, allowing summation and decision-making.
Filtering out low-level stimuli: Weak stimuli may not generate enough neurotransmitter to produce sufficient EPSPs for an action potential — threshold acts as a noise filter.
Memory and learning: Repeated stimulation of a synapse can strengthen the connection (long-term potentiation, LTP) by increasing the number of postsynaptic AMPA receptors or by enhancing transmitter release. LTP in the hippocampus is widely regarded as the cellular substrate of declarative memory.
Protection (via habituation): Continuous, non-harmful stimulation leads to a gradual reduction in transmitter release, preventing wasteful overstimulation and freeing attention for novel inputs.
Many drugs and toxins exert their effects by interfering with synaptic transmission. This is the molecular basis of psychiatric pharmacology, anaesthesia, and many natural toxins:
| Substance | Action | Effect |
|---|---|---|
| Nerve gas (e.g. sarin) | Inhibits acetylcholinesterase irreversibly | ACh accumulates → continuous stimulation → spastic paralysis, respiratory failure |
| Curare | Competitive antagonist at nicotinic ACh receptors | Prevents depolarisation → flaccid muscle paralysis |
| Nicotine | Agonist at nicotinic receptors (mimics ACh) | Stimulates postsynaptic neurone; long-term receptor down-regulation drives addiction |
| Botulinum toxin (Botox) | Cleaves SNARE proteins; prevents vesicle fusion | No ACh release → muscle relaxation / flaccid paralysis |
| Organophosphate insecticides | Inhibit acetylcholinesterase | Continuous stimulation → insect death; same mechanism as sarin at sublethal dose in humans |
| SSRI antidepressants | Block reuptake of serotonin | Serotonin remains in cleft longer → prolonged signalling at 5-HT receptors |
| Caffeine | Adenosine receptor antagonist | Blocks the inhibitory adenosine signal that normally promotes drowsiness; relevant to RP10 (lesson 7) |
| Benzodiazepines | Positive allosteric modulator of GABA-A receptor | Enhanced IPSPs → sedation, anxiolysis |
This content sits in AQA 7402 Section 3.6.2 — synaptic transmission, cholinergic synapse, summation, integration, neuromuscular junction (refer to the official AQA specification document for exact wording). Synaptic transmission is one of the highest-yield topics in 7402 and appears every series.
This lesson connects to:
Synaptic-transmission questions split AO marks predictably:
| AO | Typical share | Earned by |
|---|---|---|
| AO1 (knowledge) | 40–50% | Naming structures, listing the 12-step sequence, defining EPSP / IPSP |
| AO2 (application) | 30–40% | Explaining drug effects from mechanism; linking summation to integration |
| AO3 (analysis / evaluation) | 15–25% | Evaluating evolutionary roles of synapses; synthesising integration with reflex behaviour or memory |
Subscribe to continue reading
Get full access to this lesson and all 8 lessons in this course.